A FAIR-Decide framework for pharmaceutical R&D: FAIR data cost-benefit assessment. (2023)
Attributed to:
The UK Software Sustainability Institute: Phase 3
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.drudis.2023.103510
PubMed Identifier: 36716952
Publication URI: http://europepmc.org/abstract/MED/36716952
Type: Journal Article/Review
Volume: 28
Parent Publication: Drug discovery today
Issue: 4
ISSN: 1359-6446